.png){kind=small}
Meningococcal B (Bexsero or Trumenba)
Meningococcal disease is a name for any infection caused by bacteria called Neisseria meningitidis. It most commonly presents as Meningitis, sepsis and septicaemia (blood poisoning) which are very serious, potentially life-threatening illnesses.
The MenB vaccine protects against bacteria called “Neisseria meningitidis" type B.
The currently approved MenB vaccines are Trumenba and Bexsero; they cannot be used interchangeably. Once a course has been started, all doses should be completed using the same vaccine brand.
The Vaccine
Who can have this vaccine?
- Bexsero is licensed for people from 2 months to 50 years old.
- Trumenba is licensed for people aged 10 years and older.
Doses required
2-3 doses
Bexsero:
- 2 doses are required for people over 2 years, with at least 1 month between doses. Immune responses develop after the second dose.
- 3 doses are required for children aged from 2 months to <2 years. The doctor will advise on the right schedule based on the child's age.
Trumenba:
- The standard licensed schedule is 2 doses, given 6 months apart (0 and 6 months). Immune responses develop after the second dose.
- An alternative 3-dose schedule is also licensed. This consists of doses given at 0, 1, and 5 months and the advantage is that immune responses develop after the second dose (month 1); however, this schedule is more expensive because it requires a third dose.
Please note:
Bexsero and Trumenba cannot be used interchangeably. Once a course has been started, all doses should be completed using the same vaccine brand.
Price
Price per dose
£150
Total for all doses
£300-450
How is it given?
This is an injection in the upper arm or thigh.
Other information
Please refer to the patient leaflet for full information on this vaccine: